Autolus Therapeutics PLC (NAS:AUTL)
$ 3.26 -0.06 (-1.81%) Market Cap: 867.56 Mil Enterprise Value: 278.69 Mil PE Ratio: 0 PB Ratio: 1.82 GF Score: 58/100

Q3 2021 Autolus Therapeutics PLC Earnings Call Transcript

Nov 03, 2021 / 12:30PM GMT
Release Date Price: $5.95 (+7.40%)
Operator

Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Third Quarter 2021 Financial Results Conference Call. As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Dr. Lucinda Crabtree, Vice President, Business Strategy. Please go ahead.

Lucinda Crabtree
Autolus Therapeutics plc - VP of IR & Corporate Communications and VP of Business Strategy and Planning

Thank you, Daniel. Good morning or good afternoon, everyone, and thank you for joining us to take part in today's call on the financial results and operational highlights for the third quarter of 2021. I am Lucinda Crabtree, Vice President of Business Planning and Strategy. With me today are Dr. Christian Itin, our Chief Executive Officer; Christopher Vann, our Chief Operating Officer; and Andrew Oakley, our Chief Financial Officer.

Before we begin, I would like to remind you that during today's call, our discussion will contain forward-looking statements. All statements other than statements of historical facts on this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot